PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 16, 2018European Heart Journal568 citationsOpen Access

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

View Full Paper
PRPaul M. RidkerPLPeter LibbyJMJean MacFadyen

Key Points

Key points are not available for this paper at this time.

Abstract

ClinicalTrials.gov NCT01327846.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ridker et al. (2018) studied this question.

synapsesocial.com/papers/696308dd7247ee1819be2f31https://doi.org/10.1093/eurheartj/ehy310
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pretenders and Contenders: Inflammation, C‐Reactive Protein, and Interleukin‐62017 · 14 citations
  2. 2Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial2017 · 159 citations
  3. 3Arterial Stiffness Is Related to Systemic Inflammation in Essential Hypertension2005 · 346 citations
  4. 4C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women2000 · 5,883 citations
  5. 5Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice2017 · 1,546 citations